
    
      After being informed about the study and potential risks, all patients giving written consent
      will have a complete ophthalmological examination to determine eligibilty for study entry. At
      week 0, patients who meet the eligibility requirements will be randomized in a double blind
      manner (participant and investigator) in a 1:1 ratio to lid wipes containing terpinen-4-ol
      and sodium hyaluronate (Hy-terÂ®) or baby shampoo (twice daily).
    
  